the interaction of light with plasmons. Using state-of-the-art electron energy-loss spectroscopy, the authors have measured the plasmon frequencies with sufficient accuracy to separate surface-and bulk-plasmon components and also to resolve tiny changes in the frequency of surface plasmons with particle size. In classical electrodynamics, no size dependence is expected. However, Scholl and colleagues have observed a sizeable increase (about 15%) in the plasmon frequency of their smallest nanoparticles (roughly 2 nm across) compared with larger ones (larger than 10 nm), accompanied by a decrease in the plasmon lifetime of about 50%.
In a simple model, conduction electrons moving at about one million metres per second take approximately 10 −14 seconds to travel across a 10-nm silver particle. This is comparable to the observed plasmon lifetime of such particles, which is about 10 plasmon periods. Under the assumption that reflections of the electrons at the surface contribute to the reduction in the plasmon lifetime, a model has been formulated 5 that is widely used and accounts for the observed lifetime reduction in assemblies of sub-10-nm particles. But the increase in plasmon frequency observed by Scholl et al. 1 in their individual sub-10-nm silver particles cannot be explained by this model, and requires quantum-mechanical effects to be understood in detail and carefully accounted for.
In nanoparticles larger than 10 nm, the conduction electrons respond to electromagnetic fields as a classical electron gas. In this gas, the contribution of each electron to the plasmons cannot be observed, and the plasmon frequency is uncertain because of collisions of the electrons with each other and with the metal's atomic lattice (Fig. 1a) .
By contrast, in nanoparticles smaller than 10 nm, because there are relatively few conduction electrons participating in the plasmons (about 250 electrons in a 2-nm particle), the electrons appear at a discrete set of energy levels, which are increasingly separated from one another as the particle size is reduced. This produces individual electron transitions between occupied and unoccupied electron energy levels. The frequency jumps of these transitions are centred around a value that is higher than the plasmon frequency of large nanoparticles (Fig. 1b) , and the finite separation between the frequency jumps increases the uncertainty about the plasmon frequency and therefore reduces plasmon lifetime 6 . In fact, individual transitions cannot in general be resolved owing to the uncertainty produced by the collisions mentioned previously. Using a simplified model that incorporates the effects of individual electron transitions, Scholl et al. 1 have successfully explained their data.
By measuring the plasmon-frequency increase and lifetime reduction in sub-10-nm particles, and by modelling these effects in terms of quantum transitions, Scholl and co-workers 1 have shown that the quantum nature of conduction electrons emerges in plasmons of small nanoparticles. So far, their study has focused on spherical nanoparticles. But it is expected that quantum effects should also have a role in nanometre-sized gaps between metallic nanoparticles and in sharp metal tips. These gaps and tips can create localized plasmon 'hotspots' that are relevant for applications such as nonlinear optics 7 and ultrasensitive, single-molecule detection (for example, through an effect known as surface-enhanced Raman scattering 8 ).
Prospects for using plasmons to fabricate quantum-optics devices in robust solidstate systems also depend on the interaction between molecules and plasmon hotspots 9 . In such systems, quantum effects such as non-locality cannot be ignored because they produce sizeable plasmon-frequency shifts and reduced plasmon lifetimes. There are, of course, unknowns on the long road to understanding plasmons at the nanometre scale, but Scholl and colleagues' study is a step in that direction. ■ 
F. Javier García de Abajo is at the Instituto de
In neurological diseases known as ataxias, the lack of order is mainly one of movement: patients cannot coordinate voluntary movements because of the loss of certain neural circuits, making it difficult for them to walk, reach for objects and speak. Increasingly, researchers are finding 1,2 that the underlying cause of some hereditary ataxias is another sort of disorder -that of mitochondria, the intracellular organelles that act as the cell's powerhouses. However, we know very little about the mechanisms that trigger certain other hereditary ataxias, such as the condition known as auto somal recessive spastic ataxia of Charlevoix-Saguenay, or ARSACS. The disease is caused by mutations in the SACS gene 3 , but the link between the mutations and the neuronal loss has been unclear. Writing in Proceedings of the National Academy of Sciences, Girard et al. 4 find that mitochondrial dysfunction is just such a link, and in the process provide clues about the cellular role of the SACS-encoded protein, sacsin*.
The ataxia in ARSACS is due to a progressive loss of neurons called Purkinje cells, which are found in the cerebellum 5 , a part of the brain involved in muscle coordination. Affected patients carry mutations in both chromosomal copies of SACS, so that their cells lack functional sacsin 3, 6 . The disorder was first described 6 in 1978 in patients from the Charlevoix and Saguenay regions of Quebec, Canada, where it is much more common than in the rest of the world. One in 22 of the regions' residents carries a mutation in one of their two copies of SACSprobably brought by French immigrants four centuries ago.
To understand sacsin's functions, Girard et al. 4 analysed the location of sacsin within various types of cells, including neurons, in culture and observed that the protein co-localizes with mitochondria. Moreover, mitochondria in mouse cells in which sacsin expression had been inhibited, and in cells from patients with ARSACS, had markedly abnormal shapes: they were larger and formed more clumps than mitochondria in normal cells. The authors then generated mice that lacked the protein.
These animals progressively lost Purkinje cells as they aged, making them potential models
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Trouble in the cell's powerhouse
Studies of rare hereditary disorders are intended to find treatments, but they can also bring other discoveries. One such study links the dysfunction of a protein to that of the cell's energy producers, the mitochondria.
for studying at least some aspects of ARSACS. Taken together, Girard and colleagues' results suggest that sacsin deficiency results in unusually shaped, large mitochondria, and that this in turn leads to Purkinje-cell loss.
The shape of mitochondria is dynamically controlled by their fission and fusion. But why do unusually shaped mitochondria harm Purkinje cells more than other cells? Each Purkinje cell has many long, branching projections that form an extensive tree-like structure (Fig. 1a) , establishing about 150,000 synaptic connections with other neurons 5 . The synapses are energy-demanding because of the need for continual pumping of ions through the cell membrane -to keep the 'lines' clear for neural transmission -and thus they require functional mitochondria to be located nearby. To enter the narrow neuronal projections, small mitochondria need to be pinched off by fission from large ones 7 (Fig. 1b) . More over, fission has a role in preserving mitochondrial health by eliminating organelles that become damaged by oxidative molecules produced during normal mitochondrial activity 8 . Purkinje cells seem to be highly dependent on the quality and efficient distribution of mitochondria throughout the cell, because their robust activity carries a high oxidative burden and they have a higher number of narrow prolongations than other cells. Indeed, Girard et al. 4 find that the clumped, fused mitochondria in sacsin-deficient neurons fail to distribute into the cellular prolongations (Fig. 1c) , and that damaged mitochondria seem to be more abundant than in normal cells.
The authors' findings 4 raise several questions. For example, how does sacsin affect the size and distribution of mitochondria? Girard and colleagues propose that the protein may be needed for efficient fission of the organelle. In addition to the abnormal mitochondrial shapes in sacsin-deficient cells, the researchers 4 report that sacsin binds to the Drp1 protein, which is essential for mitochondrial division. During fission, Drp1 polymerizes to form a spiral around the outside of the organelle, constricting it and facilitating its division 9, 10 . The hypothesis that sacsin is required for full Drp1 activity is consistent with previous research 11, 12 showing that mice with brainspecific Drp1 deficiency display features similar to those observed by Girard et al. 4 in sacsin-deficient mice -a loss of Purkinje cells, together with the presence of oversized mitochondria that fail to spread into the neuronal projections. And it has been reported 8 that damaged mitochondria are not efficiently degraded in cultured cells in which Drp1 activity is inhibited. Therefore, the dependence of Purkinje cells on the shape and health of mitochondria may explain why they are preferentially lost in Drp1-and sacsin-deficient mice, and in patients with ARSACS.
Additional questions remain, such as why sacsin binds to Drp1 and how this binding may affect mitochondrial shape. Some portions of the sacsin protein are similar to chaperones (proteins that help other proteins to fold efficiently), so it is tempting to speculate that sacsin may be needed for Drp1 or other proteins involved in mitochondrial division to assume their proper conformation. The link between sacsin and Drp1 also raises the possibility that sacsin regulates the division of peroxisomes, another type of intracellular organelle. Drp1 elimination in mice results in abnormally long peroxisomes 11 , and so it would be interesting to test whether the cells of patients with ARSACS contain longer peroxisomes.
Girard and colleagues' study of ARSACS strikes a common theme in research into neuro degenerative disorders: insight from clinical studies reveals new perspectives for cell biology, and vice versa. For instance, the study of families affected by optic atrophy type 1 revealed the protein OPA1 as being essential for mitochondrial fusion 12, 13 . And research in the fruitfly revealed that the parkin protein -the dysfunction of which is the leading cause of recessive Parkinson's disease -regulates mitochondrial shape 14 . These examples demonstrate the importance of fostering interaction between the clinic and the lab. 4 find that mitochondria in sacsin-deficient mouse cells and in cells from patients with ARSACS are larger than those in normal cells and accumulate in clumps. Such large mitochondria do not distribute into the cellular prolongations in sacsin-lacking neurons. These results, together with other data from sacsin-deficient mice, suggest that mitochondrial dysfunction is involved in the death of Purkinje cells in patients with ARSACS.
